Stability study of sodium iodide (123 I) oral solution

Autores

  • Tanira Giara Mello a:1:{s:5:"pt_BR";s:31:"Instituto de Engenharia Nuclear";}
  • Erica de Araujo Lima Andrade
  • Marcilene Aparecida Silva Carmo
  • Cintia A. Custódio Instituto de Engenharia Nuclear
  • Cláudio Reis Sant'anna
  • Rosilene Fiuza Silva
  • Gonçalo Rodrigues Santos
  • Luiz Cláudio Martins Aleixo
  • Julio Cezar Suita

Resumo

Sodium iodide (123 I) produced by the Nuclear Engineering Institute (IEN) is an oral  radiopharmaceutical with a half-life of 13.2 h. It is stored at room temperature (15 - 30 ° C) and its activity is calibrated for the hospital to use the next day. The objective of this work was to evaluate the stability following ANVISA recommendations and determine your shelf life. It is concluded that all criteria for acceptance of quality requirements were met in the period of 48 h.

Linha principal do CV-28: lente quadripolar e distribuidor magnético

Downloads

Publicado

2021-08-12

Como Citar

Mello, T. G., Andrade, E. de A. L., Carmo, M. A. S., A. Custódio , C. ., Sant’anna, C. R., Silva, R. F., … Suita, J. C. (2021). Stability study of sodium iodide (123 I) oral solution . Instituto De Engenharia Nuclear: Progress Report, (4). Recuperado de https://revistas.ien.gov.br/index.php/ienprogressreport/article/view/552

Edição

n. 4 (2021): IEN - Progress Report 2018-2020 n.4

Seção

Radiopharmaceuticals Production

Licença

Copyright (c) 2021 Tanira Giara Mello, Erica de Araujo Lima Andrade, Marcilene Aparecida Silva Carmo, Cintia A. Custódio , Cláudio Reis Sant'anna, Rosilene Fiuza Silva, Gonçalo Rodrigues Santos, Luiz Cláudio Martins Aleixo, Julio Cezar Suita

Creative Commons License

Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.